IMA for stronger laws to eliminate spurious drugs

Image
Press Trust of India New Delhi
Last Updated : Apr 21 2017 | 8:48 PM IST
Welcoming Prime Minister Narendra Modi's push for generic drugs, the Indian Medical Association (IMA) today called for stronger laws to eliminate the circulation of spurious and substandard medicines in the country.
IMA has written to its three lakh members asking them to extend support to the cause and prescribe generic drugs to patients.
"To make this a reality, there is a need to address key issues such as increased penetration of spurious and substandard medicines in our country, unauthorised dispensing of generics by chemists as well as lack of dedicated fair price medical shops by the government," IMA National President, Dr K K Agarwal said.
It further said the recent inclusion of stents under the National List of Essential Medicines (NLEM) has reduced prices and all other devices and disposables should also be brought under it.
IMA further suggested that the department responsible for generic drug quality control should be brought under the Ministry of Health as it is currently under the Ministry of Chemical and Petroleum affairs.
It advised its member doctors to write 'Jan Aushadhi' on the prescription and also mention the generic name of the drug and the company name.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Apr 21 2017 | 8:48 PM IST

Next Story